PubMed COVID-19 Clinical Care
21601 - 21610 of 44979 results found
Air-water exchange and risk assessment of phthalic acid esters during the early phase of COVID-19 pandemic in tropical riverine catchments of India
Description
Given the increased load of waste plastic in the solid waste stream after the outbreak of the COVID-19 pandemic, we investigated the fate of selected plastic additives along open burning dumps, industrial and residential transects in tropical
Pediatric hemophagocytic lymphohistiocytosis after concomitant administration of SARS-CoV-2 vaccine and influenza vaccine
Description
Hemophagocytic lymphohistiocytosis (HLH) is a highly lethal disease characterized by fever, cytopenia, splenomegaly, and hemophagocytosis. Whereas infectious diseases, malignant tumors, and autoimmune diseases are often triggers for HLH, reports of
Synthesis of cannabidiol-based compounds as ACE2 inhibitors with potential application in the treatment of COVID-19
Description
Cannabis is a general name for plants of the genus Cannabis. Used as fiber, medicine, drug, for religious, therapeutic, and hedonistic purposes along the millenia, it is mostly known for its psychoactive properties. One of its major constituents
Vaccination effects on reducing COVID-19 complications in pregnancy: A large-scale report from Iran
Description
CONCLUSION: Maternal COVID-19 immunization is effective in reducing COVID-19 complications in infected pregnant women.
The intersectionality-based policy analysis framework: demonstrating utility through application to the pre-vaccine U.S. COVID-19 policy response
Description
Few guidelines exist for the development of socially responsible health policy, and frameworks that balance considerations of data, strategy, and equity are limited. The Intersectionality-Based Policy Analysis (IBPA) framework utilizes a structured
A case report of severe hyponatremia secondary to Paxlovid-induced SIADH
Description
Nirmatrelvir-ritonavir (Paxlovid) is a brand-new oral antiviral medication for treating mild to severe COVID-19. The Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for ritonavir-nirmatrelvir on December 22, 2021, to
Evaluation of berberine pellet effect on clinical recovery time in COVID-19 outpatients: A pilot clinical trial
Description
CONCLUSION: Berberine (300 mg, TID, two weeks) is ineffective in treating COVID-19. More research with a larger sample size is needed to investigate different berberine dosages in other pharmaceutical formulations.
Sense of Coherence (SOC) of Italian healthcare workers during the COVID-19 pandemic: analysis of associated factors
Description
CONCLUSIONS: This study highlights the unique challenges and stressors faced by healthcare workers during the COVID-19 pandemic and their impact on SOC. Age, length of service, geographic location, and social status were significant factors
Integrating community voices in the research continuum: Perspectives on a consultation service
Description
The Community Research Advisory Council (C-RAC) of the Johns Hopkins Institute for Clinical and Translational Research was established in 2009 to provide community-engaged research consultation services. In 2016-2017, C-RAC members and researchers
